NDC 51662-1482
Nicardipine Hydrochloride 25 mg per 10 mL injection
On the label: HF Acquisition Co. LLC. DBA HealthFirst. It's repackaged: HF Acquisition Co. LLC. DBA HealthFirst rebottles it from Hikma Pharmaceuticals USA Inc.'s NDC 0143-9689.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Hikma Pharmaceuticals USA Inc. names for other drugs.
Repackaging site
- HF Acquisition Co LLC, Mukilteo, WA, United States · relabels it
Recalls
- May 13, 2013 · Class III · West-ward Pharmaceutical Corp.
Failed Impurity/Degradation Specifications; out of specification value for impurity Nitrophenylpuridine Derivative (NPP-D)
Lots: Lot PLNJ1201 APRIL 2014 Lot PLNJ1202 MAY 2014
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Nicardipine: every company that makes it
- Form
- injection, intravenous
- Strength
- 25 mg per 10 mL
- Approval
- NDA NDA022276
- On the market since
- Feb 1, 2020
- Package NDCs
51662-1482-1- Official label
- DailyMed (National Library of Medicine), updated Jan 8, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?